questionsmedicales.fr
Eucaryotes
Animaux
Chordés
Vertébrés
Amphibiens
Anura
Bufonidae
Bufo marinus
Bufo marinus : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bufo marinus : Questions médicales les plus fréquentes",
"headline": "Bufo marinus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bufo marinus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-11",
"dateModified": "2025-05-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bufo marinus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Bufonidae",
"url": "https://questionsmedicales.fr/mesh/D002025",
"about": {
"@type": "MedicalCondition",
"name": "Bufonidae",
"code": {
"@type": "MedicalCode",
"code": "D002025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.050.150.900.090.180.210"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Bufo marinus",
"alternateName": "Bufo marinus",
"code": {
"@type": "MedicalCode",
"code": "D002024",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hongyuan Wang",
"url": "https://questionsmedicales.fr/author/Hongyuan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science, Shaanxi Normal University, Xi'an 710119, China. hongyuanwang@snnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Lihong Chai",
"url": "https://questionsmedicales.fr/author/Lihong%20Chai",
"affiliation": {
"@type": "Organization",
"name": "School of Water and Environment, Chang'an University, Xi'an 710054, China."
}
},
{
"@type": "Person",
"name": "Xinyi Li",
"url": "https://questionsmedicales.fr/author/Xinyi%20Li",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science, Shaanxi Normal University, Xi'an, 710119, China."
}
},
{
"@type": "Person",
"name": "Minyao Wu",
"url": "https://questionsmedicales.fr/author/Minyao%20Wu",
"affiliation": {
"@type": "Organization",
"name": "College of Life Science, Shaanxi Normal University, Xi'an, 710119, China."
}
},
{
"@type": "Person",
"name": "Ágnes M Móricz",
"url": "https://questionsmedicales.fr/author/%C3%81gnes%20M%20M%C3%B3ricz",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathophysiology, Plant Protection Institute, Centre for Agricultural Research, Hungarian Academy of Sciences, Herman Ottó Str. 15, Budapest, H-1022, Hungary."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An evaluation of mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36124781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17474086.2022.2125865"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional and structural characterization of Streptococcus pneumoniae pyruvate kinase involved in fosfomycin resistance.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37286036",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbc.2023.104892"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design.",
"datePublished": "2023-03-23",
"url": "https://questionsmedicales.fr/article/36958777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-063605"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics.",
"datePublished": "2022-07-06",
"url": "https://questionsmedicales.fr/article/35794729",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ptr.7534"
}
},
{
"@type": "ScholarlyArticle",
"name": "A responsive fluorescent probe for detecting and imaging pyruvate kinase M2 in live cells.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35574810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d2cc01211a"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Animaux",
"item": "https://questionsmedicales.fr/mesh/D000818"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chordés",
"item": "https://questionsmedicales.fr/mesh/D043344"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vertébrés",
"item": "https://questionsmedicales.fr/mesh/D014714"
},
{
"@type": "ListItem",
"position": 6,
"name": "Amphibiens",
"item": "https://questionsmedicales.fr/mesh/D000663"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anura",
"item": "https://questionsmedicales.fr/mesh/D001001"
},
{
"@type": "ListItem",
"position": 8,
"name": "Bufonidae",
"item": "https://questionsmedicales.fr/mesh/D002025"
},
{
"@type": "ListItem",
"position": 9,
"name": "Bufo marinus",
"item": "https://questionsmedicales.fr/mesh/D002024"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bufo marinus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bufo marinus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bufo marinus",
"description": "Comment identifier un Bufo marinus ?\nQuels tests pour diagnostiquer une intoxication ?\nQuels signes cliniques indiquent une intoxication ?\nPeut-on confondre avec d'autres espèces ?\nQuels sont les critères de gravité d'une intoxication ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bufo marinus",
"description": "Quels sont les symptômes d'une intoxication ?\nComment se manifeste une réaction allergique ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes chroniques ?\nQuels sont les signes d'une intoxication aiguë ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bufo marinus",
"description": "Comment éviter l'exposition au Bufo marinus ?\nQuelles mesures de sécurité pour les enfants ?\nLes traitements préventifs existent-ils ?\nComment gérer les populations de crapauds ?\nQuels sont les risques pour les animaux domestiques ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bufo marinus",
"description": "Quel est le traitement principal d'une intoxication ?\nComment traiter les symptômes neurologiques ?\nY a-t-il un antidote spécifique ?\nQuel rôle joue l'hydratation dans le traitement ?\nQuand faut-il hospitaliser un patient ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bufo marinus",
"description": "Quelles complications peuvent survenir ?\nLes complications sont-elles réversibles ?\nQuels sont les effets à long terme ?\nComment prévenir les complications ?\nLes complications varient-elles selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bufo marinus",
"description": "Quels sont les facteurs de risque d'intoxication ?\nLes animaux domestiques sont-ils à risque ?\nLes enfants sont-ils plus à risque ?\nY a-t-il des prédispositions génétiques ?\nComment l'environnement influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002024?mesh_terms=Pyruvate+Kinase&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un Bufo marinus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il se reconnaît par sa peau rugueuse, ses grandes glandes parotoïdes et sa taille imposante."
}
},
{
"@type": "Question",
"name": "Quels tests pour diagnostiquer une intoxication ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests cliniques et des analyses sanguines peuvent confirmer une intoxication par les toxines."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent salivation excessive, tremblements, et troubles cardiaques."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres espèces ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres crapauds peuvent avoir des caractéristiques similaires, nécessitant une identification précise."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de gravité d'une intoxication ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gravité dépend des symptômes, de la dose ingérée et de la rapidité de traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, convulsions et arythmies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réaction allergique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des démangeaisons, un gonflement et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants peuvent présenter des symptômes plus graves en raison de leur taille."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes chroniques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets à long terme peuvent inclure des troubles neurologiques après une exposition prolongée."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une intoxication aiguë ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une agitation, des spasmes musculaires et une détresse respiratoire."
}
},
{
"@type": "Question",
"name": "Comment éviter l'exposition au Bufo marinus ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez de manipuler ces crapauds et gardez les animaux domestiques éloignés des zones infestées."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité pour les enfants ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les enfants lors de jeux en extérieur et éduquez-les sur les dangers des crapauds."
}
},
{
"@type": "Question",
"name": "Les traitements préventifs existent-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitements préventifs spécifiques, mais l'éducation est essentielle."
}
},
{
"@type": "Question",
"name": "Comment gérer les populations de crapauds ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de gestion de la faune peuvent aider à contrôler les populations de Bufo marinus."
}
},
{
"@type": "Question",
"name": "Quels sont les risques pour les animaux domestiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les chiens et les chats peuvent être gravement affectés par l'ingestion de ces crapauds."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal d'une intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste en l'administration d'antidotes et de soins de soutien en milieu hospitalier."
}
},
{
"@type": "Question",
"name": "Comment traiter les symptômes neurologiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anticonvulsivants peuvent être administrés pour contrôler les convulsions."
}
},
{
"@type": "Question",
"name": "Y a-t-il un antidote spécifique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, mais des traitements symptomatiques sont efficaces."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hydratation dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation est cruciale pour prévenir la déshydratation et soutenir la fonction rénale."
}
},
{
"@type": "Question",
"name": "Quand faut-il hospitaliser un patient ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou d'exposition importante."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cardiaques, neurologiques et des lésions rénales."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement rapide, d'autres non."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets neurologiques ou cardiaques peuvent persister après une intoxication sévère."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié est essentiel pour minimiser les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes et les personnes âgées sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à l'environnement naturel du crapaud et la négligence."
}
},
{
"@type": "Question",
"name": "Les animaux domestiques sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chiens et les chats sont particulièrement vulnérables à l'intoxication par ingestion."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur curiosité et de leur tendance à manipuler des animaux inconnus."
}
},
{
"@type": "Question",
"name": "Y a-t-il des prédispositions génétiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucune prédisposition génétique n'est connue pour l'intoxication par Bufo marinus."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les zones où le Bufo marinus est présent augmentent le risque d'exposition et d'intoxication."
}
}
]
}
]
}
Pyruvate kinase deficiency (PKD) is the most common cause of congenital nonspherocytic hemolytic anemia. Until recently, treatment had been limited to supportive management including red blood cell tr...
We discuss preclinical data and phase 1, 2, and 3 clinical studies evaluating mitapivat for adult patients with hemolytic anemia secondary to PKD. Mitapivat has been shown to offer early and durable i...
Mitapivat is a first-in-class allosteric activator of pyruvate kinase and the first FDA-approved disease directed therapy for PKD. It has a favorable safety profile and clear clinical efficacy. Given ...
Glycolysis is the primary metabolic pathway in the strictly fermentative Streptococcus pneumoniae, which is a major human pathogen associated with antibiotic resistance. Pyruvate kinase (PYK) is the l...
Pyruvate kinase (PK) deficiency is a rare, under-recognised, hereditary condition that leads to chronic haemolytic anaemia and potentially serious secondary complications, such as iron overload, chole...
The Peak Registry is an observational, longitudinal, global registry of adult and paediatric patients with a genetically confirmed diagnosis of PK deficiency. The Peak Steering Committee is composed o...
Registry protocol and informed consent forms are approved by institutional review boards/independent ethics committees at each study site. The study is being conducted in accordance with the Declarati...
NCT03481738....
Glycolysis is the primary source of energy for cancer growth and metastasis. The shift in metabolism from mitochondrial oxidative phosphorylation to aerobic glycolysis is called the Warburg effect. Ca...
In this study, we designed and tested fluorescent probe zy-2 for specific and responsive imaging of pyruvate kinase M2 (PKM2), which can be excited by 419 nm light. A 17-fold enhancement in the respon...
Cancer mortality is primarily a consequence of its metastatic spread. Here, we report that methionine sulfoxide reductase A (MSRA), which can reduce oxidized methionine residues, acts as a suppressor ...
Pyruvate Kinase (PK) deficiency is the most common enzyme defect of glycolysis, leading to congenital hemolytic anemia, which can occur during the neonatal period....
We report the prenatal management of fetal anemia related to PK deficiency in a family with a severe proband....
The couple had a first child born with hydrops, whose PK deficiency was diagnosed at 18 months of life. He was treated with allogeneic bone marrow transplantation. The second child was free from disea...
When a proband is identified in a family, fetal investigation is warranted, to set up third-trimester ultrasound surveillance and perinatal management. In case of fetal severe anemia of unknown etiolo...
Pyruvate kinase deficiency (PKD) is a rare congenital hemolytic anemia. Here, we summarized the clinical features and laboratory examinations of four Chinese children with PKD and analyze genomic muta...
Collected and analyzed the clinical data of all children and their parents and completed the relevant laboratory examinations of all children. Analyzed the sequences of related genes in children by se...
A total of six mutations in gene PKLR were detected in four cases. Except for c.1510C>T (P1) and c.941T>C (P2 and P4), which had been reported in previous studies, the other four novel gene mutations ...
Compound heterozygous or homozygous mutations in the coding region of PKLR gene are the causes of PKD in these four Chinese children. The second-generation sequencing technology is an effective means ...
Human liver pyruvate kinase (hlPYK) catalyzes the final step in glycolysis, the formation of pyruvate (PYR) and ATP from phosphoenolpyruvate (PEP) and ADP. Fructose 1,6-bisphosphate (FBP), a pathway i...
Up to 70% of the cases of biliary strictures are cholangiocarcinoma. Cholangiocarcinoma has a late diagnosis and poor outcomes; therefore, effective biomarkers are needed for malignant lesions detecti...
The aim was to assess the diagnostic utility of bile pyruvate kinase M2 (PKM2) as a biomarker for the detection of malignant biliary strictures in patients with an indeterminate biliary stricture....
This is a prospective study to evaluate the diagnostic value of bile PKM2 for the diagnosis of malignant biliary strictures. Bile samples were collected during Endoscopic Retrograde Cholangio Pancreat...
Forty-six patients were recruited for the study; 19 patients with malignant strictures and 27 with benign biliary strictures. The bile PKM2 levels were elevated in patients with malignant biliary stri...
In patients with indeterminate biliary strictures, bile PKM2 may be a potential biomarker for the diagnosis of malignancy....